This website is best viewed using the
horizontal display on your tablet device.

This website is best viewed using the
vertical display on your mobile device.

Bristol Myers Squibb is dedicated to providing resources that are useful to both you and your patients from the first dose forward. Browse the pages of this section to learn more and to access the resources we offer.

Checkmate 067 Data Presentation

Checkmate 067 trial data studying
first-line metastatic melanoma
patients.

Download Data Presentation
Checkmate 238 Data Presentation

Checkmate 238 trial data studying the
adjuvant treatment of Stage III-Stage IV
NED fully resected melanoma patients.

Download Data Presentation
IMAR Guide

A quick reference to the immune-mediated adverse reactions associated with OPDIVO® treatment.

View Management Guide
Dosing Grid

Dosing schedules for all OPDIVO and OPDIVO + YERVOY® (ipilimumab) indications.

View Dosing Information
Patient Monitoring Checklist

A convenient, printable tool to help nurses identify signs and symptoms of immune-mediated adverse reactions.

View Checklist
Patient Pocket Guide

A guide that includes a compact wallet card and checklist for patients to recognize and report symptoms of immune-mediated adverse reactions.

View Pocket Guide
BMS Access and Support

Bristol Myers Squibb is committed to providing access and reimbursement support, including co-pay assistance for eligible commercially insured patients.

Learn More
Learn About Dosing
Go to Homepage